hotspot -WSS

hotspot

author：comprehensive 2025-10-01 14:38:04 - browse：89

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： With measles on the rise, a personal story of a devastating disease

WSS

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Readers respond to H5N1 and livestock movements, and more

10 states plan to sue EPA over standards for residential wood

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

NVIDIA and Google execs on the future of AI and drug discovery

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

Activists slam private health insurers over coverage restrictions

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Anesthesiologist group: stop taking Ozempic before surgery

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

NASA releases new images of 'fingerprint

BioMarin wins approval for gene therapy to treat hemophilia A

Addiction experts warn against a second 'war on drugs'

Psychedelics group wrestles with new pharma identity

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

explore

Criminal prosecution for violating HIPAA: an emerging threat

It's time to retire 'poor historian' from clinicians' vocabularies

Leon Gautier, last member of French D

Arc Institute generative AI designs new CRISPR systems

Second House panel advances two

Anxious about a speech? A startup wants you to pop a minty cardiac drug

explore

focus

entertainment

leisure time